| 000 | 01769 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516093905.0 | ||
| 264 | 0 | _c20121017 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1865-8652 | ||
| 024 | 7 |
_a10.1007/s12325-012-0023-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaas, Wolfgang | |
| 245 | 0 | 0 |
_aMicrobiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin. _h[electronic resource] |
| 260 |
_bAdvances in therapy _cMay 2012 |
||
| 300 |
_a442-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Ophthalmic |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAzepines _xadministration & dosage |
| 650 | 0 | 4 |
_aBacteria _xclassification |
| 650 | 0 | 4 | _aBacteriological Techniques |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aConjunctivitis, Bacterial _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluoroquinolones _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aGearinger, Lynne S | |
| 700 | 1 | _aHesje, Christine K | |
| 700 | 1 | _aSanfilippo, Christine M | |
| 700 | 1 | _aMorris, Timothy W | |
| 773 | 0 |
_tAdvances in therapy _gvol. 29 _gno. 5 _gp. 442-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s12325-012-0023-y _zAvailable from publisher's website |
| 999 |
_c21820476 _d21820476 |
||